Free Trial

New York State Teachers Retirement System Sells 17,103 Shares of CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

New York State Teachers Retirement System decreased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 5.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 278,858 shares of the financial services provider's stock after selling 17,103 shares during the period. New York State Teachers Retirement System owned about 0.08% of CME Group worth $73,978,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. Heartland Bank & Trust Co purchased a new stake in CME Group during the first quarter valued at approximately $377,000. Unified Investment Management purchased a new stake in CME Group during the fourth quarter valued at approximately $503,000. Aspire Growth Partners LLC purchased a new stake in CME Group during the fourth quarter valued at approximately $548,000. First Citizens Bank & Trust Co. increased its holdings in CME Group by 3.4% during the first quarter. First Citizens Bank & Trust Co. now owns 43,135 shares of the financial services provider's stock valued at $11,443,000 after buying an additional 1,408 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in CME Group by 63.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider's stock valued at $27,867,000 after buying an additional 40,592 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In other news, Director William R. Shepard bought 256 shares of the stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director now owns 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the firm's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the sale, the director now owns 5,400 shares of the company's stock, valued at $1,471,824. This trade represents a 35.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CME. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a report on Monday, March 10th. Morgan Stanley upped their target price on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. Barclays increased their price objective on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. Finally, Bank of America increased their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, CME Group has an average rating of "Hold" and an average target price of $258.20.

Check Out Our Latest Report on CME

CME Group Stock Performance

Shares of NASDAQ:CME opened at $274.76 on Monday. CME Group Inc. has a 52 week low of $193.17 and a 52 week high of $290.79. The stock has a market capitalization of $99.01 billion, a P/E ratio of 27.64, a PEG ratio of 3.73 and a beta of 0.45. The firm has a fifty day simple moving average of $275.21 and a two-hundred day simple moving average of $256.83. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business earned $2.50 EPS. On average, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines